Literature DB >> 27572270

MicroRNA-181d is a tumor suppressor in human esophageal squamous cell carcinoma inversely regulating Derlin-1.

Dejun Li1, Mo Shi2, Hongsheng Ji1, Gang Chen2, Hua Jiang2, Zhou Wang1.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is the predominant subtype of human esophageal cancer in East Asia. In the present study, we explored the tumor suppressive function of microRNA-181d (miR-181d) in ESCC. Quantitative RT-PCR was used to assess gene levels of miR‑181d in both ESCC cell lines and clinical samples. Lentiviral transduction was used to overexpress miR-181d in ECA109 and Kyse30 cells. The possible tumor suppressive effects of miR-181d overexpression on ESCC proliferation, migration and cell cycle transition in vitro, and tumorigenicity in vivo were examined. Downstream target gene of miR‑181d in ESCC, Derlin-1 (DERL1) was assessed by luciferase assay and qRT-PCR. DERL1 was also force expressed in miR‑181d-overexperssed ECA109 and Kyse30 cells to evaluate its reverse effect on miR-181d mediated tumor suppression in ESCC. miR-181d was aberrantly downregulated in both ESCC cell lines and human tumors. Lentivirus-mediated miR-181d overexpression had significant tumor suppressing functions by inhibiting cancer proliferation, migration and arresting cell cycle transition in vitro, as well as inhibiting tumorigenicity in vivo. DERL1 was identified as downstream target gene of miR-181d in ESCC cells. Forced overexpression of DERL1 in ESCC cells was shown to greatly reverse the tumor suppressive effects of miR-181d upregulation on ESCC in vitro proliferation, migration and cell cycle arrest. Out data suggest that miR-181d is a tumor suppressor in ESCC inversely regulating its downstream target gene of DERL1.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27572270     DOI: 10.3892/or.2016.5028

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  The regulatory landscape of retinoblastoma: a pathway analysis perspective.

Authors:  Laura Gómez-Romero; Diana E Alvarez-Suarez; Enrique Hernández-Lemus; M Verónica Ponce-Castañeda; Hugo Tovar
Journal:  R Soc Open Sci       Date:  2022-05-18       Impact factor: 3.653

2.  Identification of miRNAs and genes for predicting Barrett's esophagus progressing to esophageal adenocarcinoma using miRNA-mRNA integrated analysis.

Authors:  Chengjiao Yao; Yilin Li; Lihong Luo; Qin Xiong; Xiaowu Zhong; Fengjiao Xie; Peimin Feng
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

3.  MicroRNA-375-3p Suppresses Upper Tract Urothelial Carcinoma Cell Migration and Invasion via Targeting Derlin-1.

Authors:  Jhen-Hao Jhan; Wei-Chi Hsu; Yi-Chen Lee; Wei-Ming Li; A-Mei Huang; Hui-Hui Lin; Chien-Sheng Wang; Yi-Ru Wu; Ching-Chia Li; Wen-Jeng Wu; Hung-Lung Ke
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

4.  Derlin-1 is a target to improve radiotherapy effect of esophageal squamous cell carcinoma.

Authors:  Qianze Dong; Lin Fu; Yue Zhao; Yang Liu; Qingchang Li; Xueshan Qiu; Enhua Wang
Journal:  Oncotarget       Date:  2017-07-07

5.  Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma.

Authors:  Heng-Wei Liu; Peter Mingjui Lee; Oluwaseun Adebayo Bamodu; Yu-Kai Su; Iat-Hang Fong; Chi-Tai Yeh; Ming-Hsien Chien; I-Hung Kan; Chien-Min Lin
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

6.  Functionalized selenium nanoparticles for targeted siRNA delivery silence Derlin1 and promote antitumor efficacy against cervical cancer.

Authors:  Yu Xia; Guoyi Tang; Changbing Wang; Jiayu Zhong; Yi Chen; Liang Hua; Yinghua Li; Hongsheng Liu; Bing Zhu
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.